Emtricitabine/Tenofovir Disoproxil Teva

Emtricitabine/Tenofovir Disoproxil Teva is a combination medication used for HIV treatment and prevention. This oral antiretroviral therapy helps manage HIV infection and reduce transmission risk.

Emtricitabine/Tenofovir Disoproxil Teva is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. This medication works by reducing the amount of HIV in the body, helping to improve immune function and lower the risk of HIV transmission.

Common effects of Emtricitabine/Tenofovir Disoproxil Teva may include headache, nausea, diarrhea, and rash. Some individuals may experience changes in kidney function or bone density. It is important to discuss any persistent or severe side effects with a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Teva should be used with caution in individuals with kidney problems or bone disorders. Regular monitoring of kidney function and bone density is recommended. This medication should not be used by individuals allergic to emtricitabine or tenofovir disoproxil.

Emtricitabine/Tenofovir Disoproxil Teva may interact with other medications, including those that affect kidney function or bone health. It is important to inform a healthcare provider about all medications being taken, including over-the-counter drugs and supplements. Alcohol consumption should be moderated while using this medication.